Not to sound like a parody of Jerry Seinfeld here, but what's the deal with all these identical-displacement V8s from different manufacturers? We've talked about the Ford 427 vs. the Chevy 427 before, ...

In case you've faced some hurdles solving the clue, Tony winner Stroker, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, announced ...

When Goldilocks got a hankering to break into a house owned by bears, she didn't realize her name would forever be defined as "just right." Something in the "Goldilocks zone" means that it occupies a ...

USD 383 board member Katie Allen on Thursday apologized after replying to a post about the Charlie Kirk death “Well deserved.” Allen was replying to a repost on Facebook by Courtney Jane Hochman, a ...

If you’d like to see your Hot Wheels cars in motion but don’t want to spend all day flicking them across your desk (or building one of those giant orange tracks), you can put them on one of these 1:64 ...

Two people have been arrested after police found 383 corpses piled up in a private crematorium in northern Mexico's Ciudad Juarez near the U.S. border, the local prosecutor's office said Tuesday, ...

Chevrolet enthusiasts are undoubtedly familiar with the custom 383 Stroker and stock 454 engines. The Stroker is a small-block, and is a favorite of any buyer wanting to get a power boost without the ...

The difference between a stroker engine and a regular engine lies primarily in the choice of crankshaft. In the case of the 383-cubic inch stroker, engine builders would modify crankshafts designed ...

SAN FRANCISCO—Kicking off J.P. Morgan week, Dyno Therapeutics announced that Roche has exercised its option to license a novel capsid for use in a gene therapy program for an undisclosed neurological ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. In a new deal potentially worth more than $1 billion, Roche is paying Dyno $50 million upfront to ...

Roche will apply Dyno Therapeutics’ engineered adeno-associated virus (AAV) capsid platform to develop next-generation AAV vectors for gene therapies targeting unspecified neurological diseases, ...